InsidersTradesSigma
Acutus Medical, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:acutus-medical-inc-330d36US·SEC (Form 4)Mcap 2M€Healthcare
Explore the full directors' dealings record of Acutus Medical, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Acutus Medical, Inc. has published 43 insider filings. Market capitalisation: €1.6m. The latest transaction was disclosed on 21 June 2022 (Attribution). Among the most active insiders: Hinrichs James F.. The full history is accessible without an account.
43
Insider Decl.
0
Thresholds
€43m
8 ops.
Buy Volume
€32,369
1 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
0.00 €
Income statement
Revenue20.2 M€
Gross profit1.0 M€5% margin
Net income−9.5 M€-47.4% margin
Balance sheet & cash
Market cap1.6 M€
Total debt35.8 M€
Free Cash Flow−31.8 M€
Last declaration on 21 June 2022
Declarations0 total
No declarations found
0 of 0 declarations
About Acutus Medical, Inc.
Acutus Medical, Inc. is a company focused on developing technologies for the diagnosis and treatment of heart diseases. It is listed on NASDAQ under the ticker symbol ACUS.
